
Miach Orthopaedics Snags $40M to Change the Standard of Care for ACL Tears
Miach Orthopaedics — a medical device company focused on restoring torn ACLs instead of reconstructing them — recently received $40 million in funding. The capital will be used to expand the U.S. commercial rollout of the company's implantable device, which received FDA de novo clearance in 2020.